Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Base de dados
Intervalo de ano de publicação
1.
Water Environ Res ; 93(9): 1779-1788, 2021 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-33829623

RESUMO

In this study, the Water Quality Analysis Simulation Program (WASP7) was used to evaluate the transmission of hexavalent chromium (Cr(VI)) contamination in a water-sediment system and its flux into cultivated soils. The agricultural areas adjacent to the Wu River in Taiwan were taken as the study area, as these soils were heavily polluted with Cr(VI) concentrations of 2173-3271 µg/kg. The rates of accumulation of Cr(VI) are affected by the distance from the source of contamination and the size and type of cultivated areas. The highest concentrations of Cr(VI) (4.27 mg/kg) were detected in soil from Changhua city and correlated with the greater risk of gastric cancer in residents. Specifically, the risk of gastric cancer due to Cr(VI) contamination of agricultural soil was 3 × 10 - 7 - 15.2 × 10 - 6 in Taichung city (upstream) and 1.3 × 10 - 6 - 76.3 × 10 - 6 in Changhua county (downstream). The values of statistical life-years (VSLYs) were US$6.2-10 million for rice, US$42-60 million for corn, and US$360-580 million for other vegetables, respectively, each year. It is critical that techniques other than source reduction are used to reduce human exposure to Cr(VI), such as chemical oxidation or ion-exchange treatment to remove Cr(VI) from factory wastewaters, prior to their discharge into rivers. PRACTITIONER POINTS: This study evaluated the transmission of hexavalent chromium (Cr(VI)) contamination in a water-sediment-soil system. Maximum concentrations of Cr(VI) most rapidly accumulated in the smallest cultivated areas. The highest concentrations of Cr(VI) (3.3 mg/kg) were correlated with the greater risk of gastric cancer. Young children had a threefold greater risk of gastric cancer than adults. Techniques other than source reduction are prior to their discharge into rivers.


Assuntos
Cromo , Qualidade da Água , Adulto , Criança , Pré-Escolar , Cromo/análise , Custos de Cuidados de Saúde , Humanos , Solo
2.
Toxicol Appl Pharmacol ; 307: 115-122, 2016 09 15.
Artigo em Inglês | MEDLINE | ID: mdl-27475717

RESUMO

Andrographolide, a diterpenoid, is the most abundant terpenoid in Andrographis paniculata, a popular Chinese herbal medicine. Andrographolide displays diverse biological activities including hypoglycemia, hypolipidemia, anti-inflammation, and anti-tumorigenesis. Recent evidence indicates that andrographolide displays anti-obesity property by inhibiting lipogenic gene expression, however, the underlying mechanisms remain to be elucidated. In this study, the effects of andrographolide on transcription factor cascade and mitotic clonal expansion in 3T3-L1 preadipocyte differentiation into adipocyte were determined. Andrographolide dose-dependently (0-15µM) inhibited CCAAT/enhancer-binding protein α (C/EBPα) and C/EBPß mRNA and protein expression as well as peroxisome proliferator-activated receptor γ (PPARγ) protein level during the adipogenesis of 3T3-L1 cells. Concomitantly, fatty acid synthase and stearoyl-CoA desaturase expression and lipid accumulation were attenuated by andrographolide. Oil-red O staining further showed that the first 48h after the initiation of differentiation was critical for andrographolide inhibition of adipocyte formation. Andrographolide inhibited the phosphorylation of PKA and the activation of cAMP response element-binding protein (CREB) in response to a differentiation cocktail, which led to attenuated C/EBPß expression. In addition, ERK and GSK3ß-dependent C/EBPß phosphorylation was attenuated by andrographolide. Moreover, andrographolide suppressed cyclin A, cyclin E, and CDK2 expression and impaired the progression of mitotic clonal expansion (MCE) by arresting the cell cycle at the Go/G1 phase. Taken together, these results indicate that andrographolide has a potent anti-obesity action by inhibiting PKA-CREB-mediated C/EBPß expression as well as C/EBPß transcriptional activity, which halts MCE progression and attenuates C/EBPα and PPARγ expression.


Assuntos
Adipogenia/efeitos dos fármacos , Fármacos Antiobesidade/farmacologia , Proteína beta Intensificadora de Ligação a CCAAT/antagonistas & inibidores , Diterpenos/farmacologia , Células 3T3-L1 , Animais , Proteína beta Intensificadora de Ligação a CCAAT/genética , Proteína beta Intensificadora de Ligação a CCAAT/metabolismo , Ciclo Celular/efeitos dos fármacos , Diferenciação Celular/efeitos dos fármacos , Proteína de Ligação ao Elemento de Resposta ao AMP Cíclico/metabolismo , Proteínas Quinases Dependentes de AMP Cíclico/metabolismo , Camundongos , PPAR gama/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA